ArticleBlood advances2023
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
James Godfrey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it